
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Marketing & Communications from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/marketing--communications/topic/200/</link>
        <description>Articles tagged with Marketing & Communications from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Purdue puts Intermezzo DTC to bed</title>
          <description>Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.</description>
          <link>http://www.mmm-online.com/purdue-puts-intermezzo-dtc-to-bed/article/293546/</link>
          <pubDate>Thu, 16 May 2013 20:36:00 GMT</pubDate>
          <itunes:summary>Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Angelina Jolie, adherence, Sanofi, Teva, AbbVie</title>
          <description>Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&amp;D chief leaves</description>
          <link>http://www.mmm-online.com/business-briefs-angelina-jolie-adherence-sanofi-teva-abbvie/article/293341/</link>
          <pubDate>Tue, 14 May 2013 18:54:50 GMT</pubDate>
          <itunes:summary>Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&amp;D chief leaves</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Orexigen, Vivus remain in weight-loss limbo</title>
          <description>Quarterly reports show that that the weight loss category remains a cool one, but studies indicate that even the best marketing plan will have to overcome payer and pricing issues.</description>
          <link>http://www.mmm-online.com/orexigen-vivus-remain-in-weight-loss-limbo/article/292704/</link>
          <pubDate>Thu, 09 May 2013 18:03:25 GMT</pubDate>
          <itunes:summary>Quarterly reports show that that the weight loss category remains a cool one, but studies indicate that even the best marketing plan will have to overcome payer and pricing issues.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Duchesnay returns morning sickness drug to US market</title>
          <description>The first drug for morning sickness in thirty years enters the market this month.</description>
          <link>http://www.mmm-online.com/duchesnay-returns-morning-sickness-drug-to-us-market/article/291376/</link>
          <pubDate>Wed, 01 May 2013 16:12:39 GMT</pubDate>
          <itunes:summary>The first drug for morning sickness in thirty years enters the market this month.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Analysts on Qsymia: show me the payers</title>
          <description>Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board.</description>
          <link>http://www.mmm-online.com/analysts-on-qsymia-show-me-the-payers/article/289207/</link>
          <pubDate>Wed, 17 Apr 2013 16:02:11 GMT</pubDate>
          <itunes:summary>Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Reps mum on adverse events; FCC&apos;s new mHealth director; med schools tighten speaking limits</title>
          <description>A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation</description>
          <link>http://www.mmm-online.com/business-briefs-reps-mum-on-adverse-events-fccs-new-mhealth-director-med-schools-tighten-speaking-limits/article/288466/</link>
          <pubDate>Thu, 11 Apr 2013 18:05:09 GMT</pubDate>
          <itunes:summary>A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Docs to pharma marketers: you&apos;re not getting it</title>
          <description>An ePharma Summit panel of physicians takes the sheen off new marketing initiatives by telling pharmas they find them useless.</description>
          <link>http://www.mmm-online.com/docs-to-pharma-marketers-youre-not-getting-it/article/283370/</link>
          <pubDate>Thu, 07 Mar 2013 16:13:40 GMT</pubDate>
          <itunes:summary>An ePharma Summit panel of physicians takes the sheen off new marketing initiatives by telling pharmas they find them useless.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Orexigen rethinks clinical trial recruitment</title>
          <description>Orexigen slashed its clinical trial recruitment period by 14 months using marketing tactics associated with retail.</description>
          <link>http://www.mmm-online.com/orexigen-rethinks-clinical-trial-recruitment/article/277478/</link>
          <pubDate>Thu, 24 Jan 2013 18:58:38 GMT</pubDate>
          <itunes:summary>Orexigen slashed its clinical trial recruitment period by 14 months using marketing tactics associated with retail.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Elsevier samples experiential marketing</title>
          <description>The company&apos;s first-ever road show has stimulated sales for its new ClinicalKey reference tool, grabbing the attention of time-harried doctors for as long as 30 minutes during the workday.</description>
          <link>http://www.mmm-online.com/elsevier-samples-experiential-marketing/article/270780/</link>
          <pubDate>Mon, 03 Dec 2012 17:17:49 GMT</pubDate>
          <itunes:summary>The company&apos;s first-ever road show has stimulated sales for its new ClinicalKey reference tool, grabbing the attention of time-harried doctors for as long as 30 minutes during the workday.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>BI, Pfizer find new way to reach COPD patients</title>
          <description>The drugmakers bring in a life coach to help COPD patients cope.</description>
          <link>http://www.mmm-online.com/bi-pfizer-find-new-way-to-reach-copd-patients/article/268959/</link>
          <pubDate>Tue, 20 Nov 2012 14:00:00 GMT</pubDate>
          <itunes:summary>The drugmakers bring in a life coach to help COPD patients cope.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  